An Overview of Drug Delivery Systems.
Jain KK.
Methods Mol Biol. 2020;2059:1-54. doi: 10.1007/978-1-4939-9798-5_1.
Revisiting Repurposing.
Sharlow ER.
Assay Drug Dev Technol. 2016 Dec;14(10):554-556. doi: 10.1089/adt.2016.766.
Drug repurposing based on drug-drug interaction.
Zhou B, Wang R, Wu P, Kong DX.
Chem Biol Drug Des. 2015 Feb;85(2):137-44. doi: 10.1111/cbdd.12378. Epub 2014 Jul 2.
Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery.
Roy S, Dhaneshwar S, Bhasin B.
Curr Drug Res Rev. 2021;13(2):101-119. doi: 10.2174/2589977513666210211163711.
Drug interaction studies on new drug applications: current situations and regulatory views in Japan.
Nagai N.
Drug Metab Pharmacokinet. 2010;25(1):3-15. doi: 10.2133/dmpk.25.3.
Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs.
Shitara Y, Sato H, Sugiyama Y.
Annu Rev Pharmacol Toxicol. 2005;45:689-723. doi: 10.1146/annurev.pharmtox.44.101802.121444.
Potential Drug-Drug Interactions Between Anti-Cancer Drugs and Other Medications in Lung Cancer Patients: A Retrospective Study.
Pinto RA, Rao M, Roy A, Thomas L, Udupa KS, Guddattu V.
Curr Drug Saf. 2023;18(2):175-189. doi: 10.2174/1574886317666220324100356.
The Influence of Pharmacogenetics on the Clinical Relevance of Pharmacokinetic Drug-Drug Interactions: Drug-Gene, Drug-Gene-Gene and Drug-Drug-Gene Interactions.
Hahn M, Roll SC.
Pharmaceuticals (Basel). 2021 May 20;14(5):487. doi: 10.3390/ph14050487.
A guide to drug discovery: Target selection in drug discovery.
Knowles J, Gromo G.
Nat Rev Drug Discov. 2003 Jan;2(1):63-9. doi: 10.1038/nrd986.
Ampicillin-sulbactam.
Dajani AS.
Pediatr Ann. 1993 Mar;22(3):197-200. doi: 10.3928/0090-4481-19930301-10.
